Lab to Impact: Customer Discovery in Early-Stage Life Sciences

Most life science companies don't fail because the science was wrong. They fail because no one validated the problem, the customer, or the market before spending years and millions building toward them. They fail because no one left the lab — or the pitch deck — long enough to find out whether the problem they were solving was real, or whether the customer they imagined actually existed.

This webinar, moderated by Dr. Donna Rounds, associate director of Business Development and Licensing, CTL at Weill Cornell, brings together three practitioners who have confronted this challenge from radically different vantage points:

• Audrey Beckman, partner and chief innovation officer at Boomerang Ventures, who evaluates and co-builds health tech companies
• Dave Saunders, product development advisor at AiM Medical Robotics, where an MRI-guided neurosurgery robot has just completed first-in-human trials
• Dr. Amir Goldan, associate professor and serial inventor of Prism-PET and NeuroTwain at Weill Cornell Medicine, who is navigating the leap from lab to market

Join us to find out more.